Clinical Trial: Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI

U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07305324) titled 'Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI' on Dec. 01.

Brief Summary: The goal of this clinical trial is to learn whether an artificial intelligence (AI) tool called FibroX can help primary care providers better diagnose significant liver fibrosis (>=F2) and clinically significant portal hypertension in adults with metabolic dysfunction-associated steatotic liver disease (MASLD).

The main questions it aims to answer are:

* Can FibroX improve the accuracy of diagnosing significant liver fibrosis (>=F2) and clinically significant portal hypertension compared to usual care?

* Is FibroX easy to use and accept...